Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/4/2026

1. SKHY
2. PLTR
3. SNAP
4. INSP
5. THRY
6. JAZZ
7. ON
8. LIFE
9. VERX
10. CAT

Go back to Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
(NASDAQ: ANAB) Delayed: 53.66 --0 (-0%)
Previous Close $53.66    52 Week High $ 
Open $53.66    52 Week Low $ 
Day High $53.66    P/E N/A 
Day Low $53.66    EPS $ 
Volume 842